
Mom Takes Eye Off Baby for '1 Second,' Not Ready for What Attacks
A mom thought she was filming a cute video of her twins toddling around the garden, until an unexpected intervention changed everything.
Lenore Coulter, from Auckland in New Zealand, could never have predicted what she would end up capturing on camera when she picked up her phone to film twins Te Aokapurangi and Waimirirangi, who were 11 months old at the time.
"That day, the girls had been having a snack while I did some gardening. I had finished, so I let them out to play," Coulter told Newsweek. "I decided to film them because they had only just learned to walk."
What happened next came in the blink of an eye. Writing in a caption accompanying the Instagram video that documented what unfolded, Coulter said she took her eye off Waimirirangi for "1 second." That was enough time for a surprise guest to make their presence felt.
"I was trying to keep both of them on the screen, but I was more focused on Te Aokapurangi, the twin that's walking away, because she was on the move," Coulter said. "Out of nowhere, I saw Waimirirangi falling and then saw that the cat was the reason."
In the clip, the feline can be seen seemingly wrestling the young toddler to the ground with no apparent provocation.
Having a pet is a huge responsibility, but it also carries some often-overlooked benefits. Having a cat, for example, has been shown to be beneficial to your mental health.
A 2015 study published in the journal Anthrozoos saw cat owners and other adults answer a questionnaire to assess their psychological health. Based on the responses given, cat owners were found to be happier, more confident and less nervous than those without pets. The responses also indicated that they slept better; were more focused on day-to-day tasks; and problem-solved more efficiently.
This particular cat didn't seem to be doing much to aid Coulter's mental health, if the clip posted to her Instagram @life_as_lenore was anything to go by. In fact, Coulter revealed a further twist in this particular tale.
"It's not actually our cat," Coulter said. "The cat belongs to a house across the road, but he roams in and out of everyone's houses; he's not shy he comes into the house, too."
Though the feline's actions caught her off-guard, Coulter was able to deal with the situation quickly, and no real harm was done. "Once I realized, I dropped the phone and ran to her," she said. "She cried a little, but I think she was more startled than anything."
As for why the feline did it, Coulter has a pretty good idea. "I assumed the cat was getting revenge for the day before when Te Aokapurangi had been rag-dolling him. But, after reading thousands of comments on the video, I think he might have been trying to pick her up," she said.
Ultimately, Coulter was able to see the funny side of it all. While she has been dismayed to see some casting aspersions about her parenting in the comments, she said she hopes the majority of viewers just see the clip in the lighthearted manner it was intended.
"I want people to know that life is short, be present and enjoy every moment," Coulter said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
35 minutes ago
- Newsweek
New Hope for People With Asthma & Eczema
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. New understanding of a receptor key to allergic responses and anaphylaxis in conditions like asthma could offer a new treatment target for sufferers of a variety of conditions. This the promise of a study by researchers from China's Shenzhen and Wuhan universities, which have identified a mechanism that sustains the release of allergy-stimulating molecules from cells. Allergic conditions like asthma (affecting around 28 million people in the US) and eczema (31.6 million) have been on the rise in recent decades. The diseases are triggered by a type of white blood cell called mast cells, which release inflammatory molecules that promote allergic responses and create symptoms like itching, swelling and difficulty breathing. An illustration of an activated mast cell releasing histamine. An illustration of an activated mast cell releasing reactions begin when antibodies called 'lgE' produced by the immune system interact with 'FcεRI'—a receptor involved in allergies and parasite immunity—and antigens (a substance causing the immune system to react) on mast cells. This, the researchers explained, "set[s] the stage" for the release of allergic mediators. While scientists have considered targeting FcεRI as a promising treatment approach, it has so far been challenging to implement in the clinic. In the new study, however, the researchers focused on an enzyme called USP5, which controls the turnover of proteins and has been linked to inflammatory diseases like gum disease. They discovered that mast cells are dependent on USP5 to release allergy signaling molecules called histamine (hence common allergy medications called antihistamines) and β-hexosaminidase in response to lgE and antigen. The discovery, the researchers wrote, demonstrates "that USP5 may be an important target in the treatment of type I allergic diseases." Type I allergic diseases include hay fever, food allergy, anaphylaxis, most types of asthma and urticaria. "They are all IgE mediated reactions that involve mast cells as a shared target, but there are multiple pathways that contribute to their severity so it's not as simple as blocking one receptor, but it could be a useful addition to current treatment options," Dr. Elena Salagean, a consultant allergist at Holistic Allergy who was not involved in the present study, told Newsweek. Promisingly, in a mouse model of the potentially life-threatening and rapid allergic reaction, anaphylaxis, knocking out USP5 or treatment with the USP5 inhibitor called WP1130 was found to prevent mast cells from releasing the molecules and weakened allergic reactions. "The study shows a new potential target in reducing the release of histamine following contact with an allergen. Reducing histamine release from mast cells by blocking enzyme USP5 that's inside the mast cells means that less histamine will be released, so allergic reactions might be much milder," Dr. Salagean observed. "Previous studies have tried to block the whole of the mast cell receptors, with varying success. Rather than trying that, the novel part in this study is that it's targeting the receptor machinery, an enzyme called USP5 inside the cells, and by doing so, it affects how well this receptor works." Patient injecting let with auto epinephrine injector. Patient injecting let with auto epinephrine injector. Getty Images/AndreyPopov The research team also revealed that the interaction between IgE and FcεRI binding caused USP5 to perform a process called deubiquitylation, removing molecules from proteins. The biochemical modification further increased the stability of FcεRI, making the allergic reaction worse in terms of both strength and the time it lasts. "Current treatments work through various different ways, mostly blocking the downstream effects of mast cell activation. Antihistamines and steroids also block certain mediators, while biologics block chemicals and other enzymes in the allergy pathway," explained Dr. Salagean. "A USP5 inhibitor would be a direct blocker that works upstream at the control system of the mast cell receptors. By blocking this, it could reduce several mediators at the same time and reduce the strength of the mast cells response to an allergic reaction." Anaphylaxis is currently primarily treated with epinephrine (adrenaline), which can be administered with an auto-injector like an EpiPen, as well as urgent medical care. "It's all still early animal study findings but if one can design a drug that specifically targets and inhibits the USP5 enzyme, then it might have real potential. The difficulty lies in delivering it to right cells and making it selective enough, so it doesn't affect other enzymes or pathways at the same time. It's a long way out from being relevant to patients yet," added Dr. Salagean. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about allergy treatments? Let us know via health@ Reference Zhou, Z.-W., Xu, X.-T., Liang, Q.-N., Zhou, Y.-M., Hu, W.-Z., Liu, S., Jiao, Y.-X., Zhang, S.-C., Ji, K., & Chen, J.-J. (2025). USP5 deubiquitylates and stabilizes FcεRIγ to enhance IgE-induced mast cell activation and allergic inflammation. Science Signaling, 18(799).
Yahoo
an hour ago
- Yahoo
AI Can Diagnose You with This Progressive Illness — and It's 86% Accurate, Study Says
Researchers developed an AI-powered tool that prompts users to perform neurological tests in their own homesNEED TO KNOW A tool accessible via smart home devices can help diagnose people with Parkinson's disease. The AI-powered tool was developed as part of a study by scientists at University of Rochester. The tool prompts users to perform neurological tests in their own homes that involve speech, facial expression and finger movementsA tool accessible via smart home devices can help diagnose people with Parkinson's disease. The AI-powered tool, called PARK, was developed as part of a study by scientists at University of Rochester. According to the website, the tool prompts users to perform a variety of web-based neurological tests in their own homes that involve speech, facial expression and finger movements. The tasks are then analyzed to detect whether the user shows signs of Parkinson's disease. After the results are given, the tool provides personalized resources for treatment or care. Newsweek reports that the test asks users to recite two short sentences that use every letter of the alphabet at least once. Then, in mere seconds, the AI can analyze the recordings to look for patterns linked to the disease. The toll has an 86% accuracy rate, per Newsweek. PARK can be accessed by any major web browser, but the researchers also note that it can be a useful tool for smart home devices, such as Amazon Alexa or Google Assistant. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human-interest stories. "While we haven't established partnerships with these companies yet, our model is very lightweight and well-suited for such integration," computer scientist Tariq Adnan told Newsweek. "With appropriate privacy safeguards and user consent, it could operate passively or on-demand through such widely used home devices,' he added. 'Once integrated, [in theory] a user could say something like 'screen me for Parkinson's symptoms,' and the system would prompt a short sentence to be read aloud.' The tool was trained with data from over 1,300 participants in home care settings, clinical settings and at the InMotion Parkinson's disease care center in Ohio, according to Newsweek. Possible indicators for the disease include uttering sounds, pausing, breathing and adding "features of unintelligibility," according to computer science graduate student Abdelrahman Abdelkader. The researchers note that access to neurological care can be a barrier for people to receive clinical diagnoses, and believe the tool can be used to encourage people to seek medical evaluation if they suspect they have the disease. "We envision a gentle, user-centered experience. The tool would never deliver a diagnosis, rather would only flag whether a follow-up with a clinician might be worthwhile," Adnan said. Parkinson's disease is characterized by the loss of nerve cells in the brain, per Mayo Clinic. It is unknown what causes the disease, although genes and environmental factors may play a risk. The average onset of Parkinson's disease is around 70 years old. Symptoms of the disease include memory loss, trouble with language, feeling irritable, having trouble chewing and swallowing, and difficulty sleeping. Parkinson's Foundation states that about 1.1 million people in the United States have the disease. Read the original article on People


New York Post
an hour ago
- New York Post
My ‘voodoo magic' trick will get you back to sleep in seconds if you wake up in the middle of the night
Eye can't believe this works. There's nothing more frustrating than waking up in the middle of the night and struggling to get back to sleep. Thankfully, one woman may have just stumbled across a shockingly simple but effective way to ease back into slumberland. Advertisement 3 'I've tried it a couple of nights in a row and it literally works — like it's the best trick I've ever tried,' Jenna Coak says in a video on TikTok. TikTok/jenna_coak 'I saw this trick on Instagram for falling back asleep if you wake up in the middle of the night and I was like, no way does this actually work,' Jenna Coak says in a video on TikTok. 'But I've tried it a couple of nights in a row and it literally works — it's the best trick I've ever tried.' Keeping your eyes closed, you look to the right, then the left, up, down and around in a circle and around the other way — that's it. Advertisement Repeat the process as many times as needed to drift off. Coak was so blown away by this sleep hack, she said it felt like 'some type of voodoo magic.' But is there any science behind it? 'EMDR [eye movement desensitization and reprocessing] is a type of trauma therapy where patients move their eyes left and right repeatedly, in essence to calm the body while they're processing traumatic memories,' Dr. Alex Dimitriu, a psychiatrist and sleep medicine specialist, told The Post. Advertisement 3 Coak was so blown away by this sleep hack, she said it felt like 'some type of voodoo magic.' samiramay – 'There is some evidence that these eye movements may indeed increase parasympathetic nervous system activity. With the knowledge that these eye movements may have a calming effect on the nervous system, I could see how this might be beneficial for some people.' However, Dr. Stephen Carstensen, a dental sleep medicine specialist, isn't quite as convinced. Advertisement 'I can't say it doesn't work because the woman says it does, for her,' he told The Post. 'There's nothing in brain science that says it should, though, and plenty of science to say it should not.' He's especially dubious about its ability to shepherd forward the dream sleep stage known as REM. 3 Keeping your eyes closed, you look to the right, then the left, up, down and around in a circle and around the other way — that's it. Andrii Lysenko – 'REM is a special part of sleep that can't be controlled or started by a conscious effort,' he said. 'The brain can't be tricked into thinking it is in REM. Science doesn't know why the eyes move during REM; during this phase they just dart back and forth, not rolling in opposite directions. That takes brain control, which means the brain is not asleep.' However, he admits that it's possible that just thinking about the trick — as opposed to something more stressful — was what made it work. Advertisement 'I think the woman was ready to fall back to sleep and maybe thinking about something simple like eye movement kept her from having more troublesome thoughts,' he said. Dimitriu agrees — at the end of the day, it's all about the mind. 'Not thinking and not stressing and anything that can keep your mind clear will likely help your sleep,' he said. Advertisement 'If focusing on eye movements or breath clears your mind, use it! Just don't go near that phone!' Other techniques that he recommends include box breathing — breathing in for 3 seconds, holding the breath for 4 seconds and exhaling for 7 — and repeatedly tightening and relaxing the muscles throughout the body, also known as systemic relaxation.